Experimental CAR T-Cell therapy takes on tough lymphoma
Disease control
Recruiting now
This study tests a new treatment called MB-105 for people with a type of blood cancer called T-cell lymphoma that has come back or not responded to standard treatments. MB-105 is made from the patient's own immune cells, which are modified to better recognize and attack cancer ce…
Phase: PHASE2 • Sponsor: March Biosciences Inc • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC